Wendy J. Betts has exercised stock options for 3,286 shares of Cardio Diagnostics Holdings, Inc., according to a recent filing. This action, reported on October 2, 2026, is significant as it showcases the company's strategy to incentivize its directors and align their interests with shareholders.
Cardio Diagnostics Holdings, Inc. is a company focused on the development of diagnostic solutions in the healthcare sector. The firm is categorized under the SIC code for in vitro and in vivo diagnostic substances. Its business address is located at 311 W. Superior Street, Suite 444, Chicago, IL. The company is publicly traded under the ticker symbol CDIO.
According to the filing, Betts exercised stock options at a conversion price of $1.90 per share on September 30, 2026. Following this transaction, she now owns a total of 15,656 shares of the company. The filing noted, "Transaction code A" indicating the acquisition of shares through the exercise of options.
This move may have several implications. It reflects Betts' confidence in the company's prospects and could encourage other directors and officers to consider similar actions. This could lead to a more engaged leadership team, which is vital for the growth and innovation within the in vitro and in vivo diagnostic substances sector.
The filing does not specify what happens next regarding additional transactions or upcoming announcements from Cardio Diagnostics Holdings, Inc.